GlobeNewswire

Real People Investment Holdings Limited – Early Partial Redemption of Nordic Senior Bonds with Excess Cash and Minor Corrections of the Terms and Conditions

Del

Real People Investment Holdings Limited up to SEK 260,000,000 and up to NOK 135,000,000 Senior Unsecured Callable Bonds 2013/2022 ISIN: SE 000 5392560 and NO 001 0689342 (the "Bonds")

Johannesburg, 13 September 2018

Reference is made to the terms and conditions for the Bonds, originally dated 16 September 2013, as amended and restated by an amendment and restatement agreement dated 5 December 2017 (the "Terms and Conditions").

Correction of the scheduled amortisations and the cost to income ratio

It has been discovered that the provision regulating scheduled amortisations set out in Clause 10 (Amortisation) of the Terms and Conditions for technical reasons by mistake refers to the Capital Nominal Amount from time to time rather than the Capital Nominal Amount as of 31 March 2018. This deviates from the corresponding provision in the Senior Unsecured Loan Agreement (as defined in the Terms and Conditions) and the repayment profile that were set out in the notice for written procedure published on 10 November 2017 (the "Notice for Written Procedure"). Such deviation would result in slightly lower payments to the Bondholders than pro rata with the Senior Lenders.

The Agent and Real People Investment Holdings Limited (the "Company") have agreed to rectify this obvious mistake by amending the first row of the table in Clause 10 (Amortisation) of the Terms and Conditions as set out below:

Amortisation date Amortisation amount (SEK Bonds) per cent. of the Capital Nominal Amount outstanding as of 31 March 2018 (SEK 80,079,703.92) set out below)* Amortisation amount (NOK Bonds) per cent. of the Capital Nominal Amount outstanding as of 31 March 2018 (NOK 62,324,904.63) set out below)*

(*new added wording has been marked with double underline)

Furthermore, a typo has been discovered in paragraph (c) of Clause 14.2 (Financial condition) of the Terms and Conditions. Pursuant to the current wording of the Terms and Conditions, the Cost to Income Ratio (as defined therein) shall not be less than or equal to 0.68:1.00. This deviates from the covenant structure set out in the summary of the amendments to the Terms and Conditions in the Notice for Written Procedure, pursuant to which the Cost to Income Ratio should not be greater than 0.68:1.00. The Agent and the Company have agreed to rectify this obvious error by amending paragraph (c) of Clause 14.2 (Financial condition) of the Terms and Conditions by replacing the words "less than or equal to" with "greater than" as set out on the following page:

Cost to Income Ratio: the Cost to Income Ratio in respect of any Measurement Period shall not be less than or equal to greater than 0.68: 1.00.

(deleted wording has been marked with strike-through and new added wording with double underline)

The amendments are made pursuant to sub-paragraph (a)(ii) of Clause 21 (Amendments and Waivers) of the Terms and Conditions. The amendments take effect as from (and including) 28 September 2018.

Repayment of excess cash

The Company has decided to use excess cash to partially repay certain debt owed to its senior creditors on a pro rata basis. As a part of such repayments, the Company will make an early partial redemption of the Bonds pursuant to Clause 11 (Cash Sweep) of the Terms and Conditions and as further set out below.

Payment details

SEK Bonds ( ISIN: SE 000 5392560)

The SEK Bonds will be partially redeemed on 28 September 2018 in a total amount of SEK 3,632,491.08, which includes both the amortisation scheduled to be made pursuant to Clause 10 (Amortisation) of the Terms and Conditions (amended as set out above) and the repayment of excess cash descried above. The record date, on which a bondholder must hold SEK Bonds in order to receive the redeemed amount, will be 21 September 2018.

The partial redemption of the SEK Bonds will be made as partial prepayments of all outstanding SEK Bonds by way of reducing the registered Nominal Amount of each SEK Bond with an amount of SEK 28 020. Due to the fact that the Nominal Amount registered with the CSD does not include capitalised interest, the repayment will appear to be made at a price of 102.07813% of the amount by which the registered Nominal Amount will be reduced as a result of the repayment. The amount is rounded down to the nearest SEK 1.00 per SEK Bond.

NOK Bonds (ISIN: NO 001 0689342)

The NOK Bonds will be partially redeemed on 28 September 2018 in a total amount of NOK 2 827 187.88, which includes both the amortisation scheduled to be made pursuant to Clause 10 (Amortisation) of the Terms and Conditions (amended as set out above) and the repayment of excess cash described above. The record date, on which a bondholder must hold NOK Bonds in order to receive the redeemed amount, will be 26 September 2018.

The partial redemption of the NOK Bonds will be made by pro rata payments to the bondholders holding NOK Bonds through redeeming NOK Bonds with a total registered Nominal Amount of 2 762 931.00. Due to the fact that that the outstanding Nominal Amount registered with the CSD does not include capitalised interest, the repayment will appear to be made at a price of 102.325678% of the amount by which the registered Nominal Amount will be reduced as a result of the redemption. The amount is rounded down to effect a pro rata repayment to the bondholders in accordance with the rules of the CSD.

For further information, please contact:

Carmen Wilkinson – Group Secretary

Email: CWilkinson@realpeople.co.za

Neil Grobbelaar – Group CEO

Email: NGrobbelaar@realpeople.co.za

This information is information that Real People Investment Holdings Limited is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 14:00 CET on 13 September 2018.

Attachment

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

Bio-Fence announces a breakthrough in Food Safety18.1.2019 08:11Pressemelding

The company have successfully completed a field trial of its new anti-microbial coating technology. The trials demonstrated a significant reduction in bacterial contamination during sensitive food production processes ASHDOD, Israel, Jan. 18, 2019 (GLOBE NEWSWIRE) -- Bio-Fence innovating coating technology announced today the successful completion of an intensive field trial on its innovative anti-microbial technology Pentagon. The trial was held in "Milouoff" (http://www.milouoff.co.il), one of the largest Ready to Eat poultry production sites in Israel and demonstrated superior results for Bio-Fence technology compared to alternatives. According to Mrs. Shiran Davidi, QA manager at Milouoff: “Bio-Fence technology seems to have clear benefits over existing antimicrobial solution. It is safe, highly potent and rechargeable.” The trial involved monitoring the performance of an epoxy floor coated with Bio-Fence anti-microbial technology compared to either commercial Silver Ion coating an

ERYTECH Presents TRYbeCA-1 Trial-in-Progress Poster at the 2019 ASCO GI Annual Meeting18.1.2019 07:00Pressemelding

LYON, France and CAMBRIDGE, Mass., Jan. 18, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells, announced that a poster entitled “TRYbeCA-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441)” will be presented today at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting in San Francisco. The poster (Abstract # TPS471) will be available at www.erytech.com after presentation at the conference. In September 2018, the TRYbeCA-1 trial was initiated. The Trial-in-Progress poster will provide an update on the study progress with investigators sites that have been initiated in multiple countries and actively recruiting patients. The trial is planned to enroll approximately 500 patients with

Fossil Group Enters Agreement To Sell Select Smartwatch Technology To Google17.1.2019 18:30Pressemelding

Transaction Unlocks Growth Opportunities for Fossil Group’s Wearables Business RICHARDSON, Texas, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Today, Fossil Group (NASDAQ:FOSL) announced its plan to sell to Google for $40 million intellectual property (IP) related to a smartwatch technology currently under development by Fossil Group. As part of the transaction, a portion of Fossil Group’s research and development (R&D) team currently supporting the transferring IP will join Google. Fossil Group retains more than 200 R&D team members to focus on innovation and product development. The transaction showcases Fossil Group and Google’s shared investment in the wearables industry. In recent years, smartwatches have become Fossil Group’s fastest growing category. The company successfully developed and launched smartwatches across 14 of its owned and licensed brands. “Fossil Group has experienced significant success in its wearables business by focusing on product design and development informed by our

Calgon Carbon Corporation Announces Global Price Increase17.1.2019 17:16Pressemelding

Pittsburgh, PA, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Calgon Carbon Corporation today announced a global price increase, effective February 1, 2019, where contracts permit, on all activated carbon products and related equipment due to a continued escalation in raw material costs and transportation expenses. The increase is expected to range between 10-15%, depending on the specific product, raw material type, services provided, and global market dynamics. The primary raw materials used for producing activated carbon are coal, coconut shell, and wood, each of which has gone up in price. Additionally, costs associated with both operating manufacturing facilities and transporting materials have also escalated. “Calgon Carbon’s raw material costs have increased significantly. Despite every effort to offset these increases through continuous improvements, the recent rise in raw material costs has exceeded our efforts,” said Jim Coccagno, Chief Commercial Officer for Calgon Carbon Corporation. “

Taconic Biosciences’ Animals Complete Most Recent Mission to the International Space Station17.1.2019 15:29Pressemelding

RENSSELAER, N.Y., Jan. 17, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces the completion of a recent mission to the International Space Station. This project represents a collaboration between the International Space Station (ISS) National Lab, National Aeronautics and Space Administration (NASA), Bioserve Space Technologies with support from the Leidos Corporation, and Taconic. Taconic has participated in several spaceflight missions with NASA since 1985. Most recently, as part of the science and research investigation payloads supported by the SpaceX Commercial Resupply Services missions, Taconic prepared mice to live aboard the International Space Station for extended periods. Previous spaceflight studies demonstrated that mice undergo rapid loss of muscle and bone mass, resembling accelerated aging. Therefore, mice exposed to microgravity via spaceflight are a valuable model to understand and devel

MPP Global Bridges the Innovation Gap by Centralising Physical and Digital Subscriber Management and Billing in a Single Cloud Platform17.1.2019 12:29Pressemelding

WARRINGTON, UK, Jan. 17, 2019 (GLOBE NEWSWIRE) -- MPP Global, the technology company that delivers eSuite, the world’s smartest subscriber management & billing platform, announces the launch of pivotal new functionality which enables media organisations to seamlessly create and manage the sale of physical subscriptions. This positions eSuite as the complete physical and digital subscription management solution. The development of this industry-first functionality was borne out of the common challenge for publishers when managing multiple systems for deploying bundled print and digital subscriptions. This is inflexible for publishers and limits choice for their customers, restricting the ability to seamlessly create and offer digital and print subscription bundles. Despite increased consumer uptake of digital subscriptions, print still accounts for almost 90% of circulation revenues globally. To drive reader revenues successfully, publishers require functionality to execute complementar